SlideShare a Scribd company logo
1 of 25
Exploring cellular and molecular
aspects of the immune system in
Locusta migratoria
Tewodros Firdissa Duressa
Public defense
October 2015
ARENBERG DOCTORAL SCHOOL
FACULTY OF SCIENCE
INTRODUCTION
Book of Exodus (Old testament)
Madagascar 2013
National Geographic society ©2015
Locust range
INTRODUCTION
Chemical
insecticides
Biocontrol Entomopathogens
Locust pathogen Organism
Metarhizium spp. Fungi
Amphimermis spp. Nematod
H. megidis and St. feltiae Nematod
Nosema maroccams Protozoan
Scello fulgidus Wasp
Tarsonemidae spp Mite
Trichopsidea oestracea Fly
Blaesoxipha spp Fly
Entomopoxviruses Viruses
INTRODUCTION
Host defense mechanism
(Immunity)
Pathogen offense mechanism
(Virulence)
Virus
Bacteria
Fungi Insects
Worms
INSECT IMMUNITY
Pathogen
recognition
Immune
response
Infection
Injury
Exoskeleton
Innate
Adaptive
PAMP ⇔ PRR
INNATE IMMUNITY
Cellular response
Humoral response
- Fat body
- Anti-microbial peptides
- Prophenol oxidase
enzymatic cascade
- Lysozymes
- Coagulation factors
- Hemocytes
- Phagocytic organs
(Hematopoietic organs)
CELLULAR IMMUNITY
Hemocytes Phagocytic organ
(Hematopoietic organ)
HPO
Dorsal vessel
Phagocytosis Nodulation Encapsulation
Prohemocyte Plasmatocyte Granulocyte
Coagulocyte Oenocytoids Spherulocyte
CELLULAR IMMUNITY
Direct cellular
immune signals
Cytokine based
immune signaling
Hemocoel
⇔
Hemocyte
recruitment
CELLULAR IMMUNITY
Infection site
Hemocyte
proliferation
Plasmatocytes
Granulocytes
Plasmatocytes
Prohemocytes
Hematopoietic organHemocoel
⇔
CELLULAR IMMUNITY
Hemocoel
0
2
4
6
8
10
0 h 0,5 h 3 h 6 h 24 h 48 h 72 h
Hemocytedensity
(x1000/µL)
NaCl/Pi β-1,3-glucan
?
?
?
RESEARCH QUESTIONS
#1. Patterns and sites of hemocyte proliferation following an
infection (circulating hemocytes, hematopoietic organ)?
#3. Identification of cytokines involved in hemocyte recruitment
during infection (cellular response, hemocyte proliferation)?
#2. Development of a cell line (primary cell culture) using
hemocytes or cells of hematopoietic organ?
#4. Functional characterization of locust orthologue of angiotensin
converting enzyme in the locust immune system?
#1. Patterns and sites of hemocyte proliferation following an
infection (circulating hemocytes, hematopoietic organ)?
#3. Identification of cytokines involved in hemocyte
recruitment during infection (cellular response,
hemocyte proliferation)?
5-bromo-2’-
deoxyuridine
(BrdU)
Histone 3
Serine 10
phosphorylation
(H3S10P)
RESULTS: HEMOCYTE PROLIFERATION
A C G T A
| | | | |
T G C A ?
0
5
10
15
20
30h BrdU 30h BrdU +
6h NaCl/Pi
30h BrdU +
6h β-1,3-
glucan
%BrdUpositivehemocytes
P<0.001
DAPI BrdU Merge
Circulating hemocytes
30 h BrdU and 6 h β-1,3-glucan
RESULTS: HEMOCYTE PROLIFERATION
BrdU
BrdU +
β-1,3-glucan
Hemocyte
smear
0.0
0.5
1.0
1.5
2.0
2.5
Naive 3 6
Mitoticindex
Hours post β-1,3-glucan
injection
P< 001
P<0.05H3S10PDAPI
BrdU Merge
RESULTS: HEMOCYTE PROLIFERATION
Hematopoietic organ: 30 h BrdU
DAPI H3S10P MergeBrdUBF
10 µm
10 µm
Circulating hemocytes
RESULTS: HEMOCYTE PROLIFERATION
dv
dv
TUNELDAPI
Hematopoietic organ
6 h β-1,3-glucan
0
10
20
30
40
50
4 d (+ 3 d) 6 d (+ 5 d)
%BrdUpositivecells
Time in days
BrdU
BrdU + β-1,3-glucan
HPO
Hematopoietic organ
4 d BrdU
Nodule
footprint
Hematopoietic organ
4 d BrdU and
3 d β-1,3-glucan
Hematopoietic organ 6 h post injection of
S. lutea (left) and C. albicans (right)
RESULTS: HEMOCYTE PROLIFERATION
Circulating
hemocytes
Patterns and sites of hemocyte proliferation following an infection
(circulating hemocytes, hematopoietic organ)?
Hemocoel
0
2
4
6
8
10
0 h 0,5 h 3 h 6 h 24 h 48 h 72 h
Hemocytedensity
(x1000/µL)
NaCl/Pi β-1,3-glucan
RESEARCH QUESTION #2
Hemocoel
?
Insect cytokines
- Toll ligand (Spaëtzle)
- Unpaired 3
- Vago
- Growth blocking peptide (GBP)
Hemocyte (plasmatocyte)
+GBP
[R/R] x(5-9)Cx2Gx(4-6)Gx(1-2)C[K/R]
GBPN- -CSP
19-30 amino acid residues (≤ 3 kD)
Hemolymph
collection (20 mL)
Hemocyte-free
hemolymph
(Serum)
Serum fraction
( > 30 kD)
Serum fraction
( < 30 kD)
Control (-ve)
0.1x
Lm-serum < 30 kD
0.1x 0.1x
> 30 kD
RESULTS: LOCUST GBP IDENTIFICATION
Serum fractionation
(30 kD MWCO filter)
RESULTS: LOCUST GBP IDENTIFICATION
0 10 20 30
minutes
0
2
4
mAU(x1000)
0
40
80
%ACN
214nm,4nm (1.00)
High-Performance
Liquid Chromatography (HPLC)
Matrix-Assisted
Laser Desorption/Ionization
Mass Spectrometry
(MALDI MS)
< 30 kD Serum fractionation
Liquid chromatography-mass
spectrometry
(LC-MS/MS)
Intens(a.u.)
m/z
Von Willebrand
factor type C
Pacifastin
Locust GBP
RMIRLGDRCPAGTVQVLG
TCRRVQKVNR
RESULTS: LOCUST GBP IDENTIFICATION
Control
Lm GBP (1 nM)
U
S
0
50
100
0.01 0.1 1 10 100 1000
%hemocytespreading
Concentration (nM)
Control Lm GBP
P < 0.05
P < 0.0001
Exon Intron
Cytoplasm
Nucleus
RNA
mRNAAAA
Structure of locust GBP encoding gene
Expression profile of locust GBP encoding gene
mRNAAAA
Protein
RESULTS: LOCUST GBP IDENTIFICATION AND CHARACTERIZATION
Hemocoel
ProGBP
GBP
RESULTS: LOCUST GBP IDENTIFICATION AND CHARACTERIZATION
-1
0
1
2
HE FB BR VNC GL CA CC FM GT MT OV TE MAG
Relativequantities(Log10)
Immune
system
Central nervous
system
Endocrine
glands
Muscle Digestive
tract
Reproductive
system
**
**
**
****
*
Expression profile of locust GBP encoding gene
0
2
4
6
8
10
0 h 0,5 h 3 h 6 h 24 h 48 h 72 h
Hemocytedensity
(x1000/µL)
NaCl/Pi β-1,3-glucan
Hemocoel
Locust
GBP
RESULTS: LOCUST GBP IDENTIFICATION AND CHARACTERIZATION
Identification of cytokines involved in hemocyte recruitment during infection (cellular response,
hemocyte proliferation)?
0
2
4
6
8
10
0 h 0,5 h 3 h 6 h 24 h 48 h 72 h
Hemocytedensity
(x1000/µL)
NaCl/Pi β-1,3-glucan
FUTURE PROSPECTS
Hemocoel
Locust
GBP
Circulating
hemocytes
Function of locust GBP
- Molecular mechanisms?
- Functional studies
(hemocyte proliferation, cross-talk and energy trade-offs)?
- Solitary vs gregarious locust immunity?
Hemocytes and phagocytic/hematopoietic organ
- Other sources and hematopoietic organ as secondary roles
in hemocyte production?
- Prophylaxis (solitary vs gregarious)?
- Translational research?
ACKNOWLEDGMENT
Prof. Roger Huybrechts
Luc Vanden Bosch
Dr. Kurt Boonen
Ria Vanlaer
Prof. Yoichi Hayakawa
Saga University, Japan
Prof. Lieve Van Mellaert, Rega Institute, Leuven
Dr. Heiko Vogel, Max Plank Institute, Germany
Prof. Veerle M. Darras
Prof. Jozef Vanden Broeck
Prof. Lieve Moons
Prof. Dirk C. de Graaf
Dr. Niels Wynant
Dr. Sven Zels
HSV-lab members
Prof. Arckens-lab members
Project students

More Related Content

Similar to Public defense2015

Recombinant protein expression and purification Lecture
Recombinant protein expression and purification LectureRecombinant protein expression and purification Lecture
Recombinant protein expression and purification Lecturetest
 
Bacterial Periplasmic Binding Proteins as Biosensors in Liposomes
Bacterial Periplasmic Binding Proteins as Biosensors in LiposomesBacterial Periplasmic Binding Proteins as Biosensors in Liposomes
Bacterial Periplasmic Binding Proteins as Biosensors in LiposomesHeather Jordan
 
Antimicrobial Activity Of Human Prion Protein Is Mediated By Its N Terminal R...
Antimicrobial Activity Of Human Prion Protein Is Mediated By Its N Terminal R...Antimicrobial Activity Of Human Prion Protein Is Mediated By Its N Terminal R...
Antimicrobial Activity Of Human Prion Protein Is Mediated By Its N Terminal R...Alfonso Enrique Islas Rodríguez
 
Regulacion de la expresion genica 2011- medical biotechnology
Regulacion de la expresion genica 2011- medical biotechnologyRegulacion de la expresion genica 2011- medical biotechnology
Regulacion de la expresion genica 2011- medical biotechnologydiegogabrielprado
 
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...Qing Chen
 
Cox2002-Automated_selection_of_aptamers_against_protein_targets_translated_in...
Cox2002-Automated_selection_of_aptamers_against_protein_targets_translated_in...Cox2002-Automated_selection_of_aptamers_against_protein_targets_translated_in...
Cox2002-Automated_selection_of_aptamers_against_protein_targets_translated_in...J. Colin Cox
 
Dr. Robert Langer - Simposio Internacional 'Terapias oncológicas avanzadas'
Dr. Robert Langer - Simposio Internacional 'Terapias oncológicas avanzadas'Dr. Robert Langer - Simposio Internacional 'Terapias oncológicas avanzadas'
Dr. Robert Langer - Simposio Internacional 'Terapias oncológicas avanzadas'Fundación Ramón Areces
 
MDC Connects: Cell-based screening: Old dogs with new tricks
MDC Connects: Cell-based screening: Old dogs with new tricksMDC Connects: Cell-based screening: Old dogs with new tricks
MDC Connects: Cell-based screening: Old dogs with new tricksMedicines Discovery Catapult
 
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein FamilyDiscriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein FamilyChris Southan
 
GM Food Allergy Biomarkers
GM Food Allergy BiomarkersGM Food Allergy Biomarkers
GM Food Allergy BiomarkersMainul Husain
 
Archakov A. from human genome project to human proteome project
Archakov A. from human genome project to human proteome projectArchakov A. from human genome project to human proteome project
Archakov A. from human genome project to human proteome projectigorod
 
Oncodesign aacr 2018 development of a high throughput in vitro screening pl...
Oncodesign aacr 2018   development of a high throughput in vitro screening pl...Oncodesign aacr 2018   development of a high throughput in vitro screening pl...
Oncodesign aacr 2018 development of a high throughput in vitro screening pl...Florence Fombertasse
 

Similar to Public defense2015 (20)

CClement ASMS St Louis May31st-June 4th 2015 talk
CClement ASMS St Louis May31st-June 4th 2015 talkCClement ASMS St Louis May31st-June 4th 2015 talk
CClement ASMS St Louis May31st-June 4th 2015 talk
 
Cristina Clement L08 presentation YI APS 2015 Orlando Florida
Cristina Clement L08 presentation YI APS 2015 Orlando FloridaCristina Clement L08 presentation YI APS 2015 Orlando Florida
Cristina Clement L08 presentation YI APS 2015 Orlando Florida
 
Recombinant protein expression and purification Lecture
Recombinant protein expression and purification LectureRecombinant protein expression and purification Lecture
Recombinant protein expression and purification Lecture
 
The in vitro choice_M.Dusinska_2013
The in vitro choice_M.Dusinska_2013The in vitro choice_M.Dusinska_2013
The in vitro choice_M.Dusinska_2013
 
Bacterial Periplasmic Binding Proteins as Biosensors in Liposomes
Bacterial Periplasmic Binding Proteins as Biosensors in LiposomesBacterial Periplasmic Binding Proteins as Biosensors in Liposomes
Bacterial Periplasmic Binding Proteins as Biosensors in Liposomes
 
Antimicrobial Activity Of Human Prion Protein Is Mediated By Its N Terminal R...
Antimicrobial Activity Of Human Prion Protein Is Mediated By Its N Terminal R...Antimicrobial Activity Of Human Prion Protein Is Mediated By Its N Terminal R...
Antimicrobial Activity Of Human Prion Protein Is Mediated By Its N Terminal R...
 
Regulacion de la expresion genica 2011- medical biotechnology
Regulacion de la expresion genica 2011- medical biotechnologyRegulacion de la expresion genica 2011- medical biotechnology
Regulacion de la expresion genica 2011- medical biotechnology
 
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
 
Sfnge array poster
Sfnge array posterSfnge array poster
Sfnge array poster
 
Cox2002-Automated_selection_of_aptamers_against_protein_targets_translated_in...
Cox2002-Automated_selection_of_aptamers_against_protein_targets_translated_in...Cox2002-Automated_selection_of_aptamers_against_protein_targets_translated_in...
Cox2002-Automated_selection_of_aptamers_against_protein_targets_translated_in...
 
Dr. Robert Langer - Simposio Internacional 'Terapias oncológicas avanzadas'
Dr. Robert Langer - Simposio Internacional 'Terapias oncológicas avanzadas'Dr. Robert Langer - Simposio Internacional 'Terapias oncológicas avanzadas'
Dr. Robert Langer - Simposio Internacional 'Terapias oncológicas avanzadas'
 
J.pi5
J.pi5J.pi5
J.pi5
 
Oligosaccharide Analysis Using High-Performance Anion-Exchange Chromatography...
Oligosaccharide Analysis Using High-Performance Anion-Exchange Chromatography...Oligosaccharide Analysis Using High-Performance Anion-Exchange Chromatography...
Oligosaccharide Analysis Using High-Performance Anion-Exchange Chromatography...
 
MDC Connects: Cell-based screening: Old dogs with new tricks
MDC Connects: Cell-based screening: Old dogs with new tricksMDC Connects: Cell-based screening: Old dogs with new tricks
MDC Connects: Cell-based screening: Old dogs with new tricks
 
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein FamilyDiscriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
 
ASMS_Poster_TSG
ASMS_Poster_TSGASMS_Poster_TSG
ASMS_Poster_TSG
 
GM Food Allergy Biomarkers
GM Food Allergy BiomarkersGM Food Allergy Biomarkers
GM Food Allergy Biomarkers
 
Archakov A. from human genome project to human proteome project
Archakov A. from human genome project to human proteome projectArchakov A. from human genome project to human proteome project
Archakov A. from human genome project to human proteome project
 
bio-intro
bio-introbio-intro
bio-intro
 
Oncodesign aacr 2018 development of a high throughput in vitro screening pl...
Oncodesign aacr 2018   development of a high throughput in vitro screening pl...Oncodesign aacr 2018   development of a high throughput in vitro screening pl...
Oncodesign aacr 2018 development of a high throughput in vitro screening pl...
 

Public defense2015

  • 1. Exploring cellular and molecular aspects of the immune system in Locusta migratoria Tewodros Firdissa Duressa Public defense October 2015 ARENBERG DOCTORAL SCHOOL FACULTY OF SCIENCE
  • 2. INTRODUCTION Book of Exodus (Old testament) Madagascar 2013 National Geographic society ©2015 Locust range
  • 3. INTRODUCTION Chemical insecticides Biocontrol Entomopathogens Locust pathogen Organism Metarhizium spp. Fungi Amphimermis spp. Nematod H. megidis and St. feltiae Nematod Nosema maroccams Protozoan Scello fulgidus Wasp Tarsonemidae spp Mite Trichopsidea oestracea Fly Blaesoxipha spp Fly Entomopoxviruses Viruses
  • 4. INTRODUCTION Host defense mechanism (Immunity) Pathogen offense mechanism (Virulence) Virus Bacteria Fungi Insects Worms
  • 6. INNATE IMMUNITY Cellular response Humoral response - Fat body - Anti-microbial peptides - Prophenol oxidase enzymatic cascade - Lysozymes - Coagulation factors - Hemocytes - Phagocytic organs (Hematopoietic organs)
  • 7. CELLULAR IMMUNITY Hemocytes Phagocytic organ (Hematopoietic organ) HPO Dorsal vessel Phagocytosis Nodulation Encapsulation Prohemocyte Plasmatocyte Granulocyte Coagulocyte Oenocytoids Spherulocyte
  • 8. CELLULAR IMMUNITY Direct cellular immune signals Cytokine based immune signaling Hemocoel ⇔ Hemocyte recruitment
  • 10. CELLULAR IMMUNITY Hemocoel 0 2 4 6 8 10 0 h 0,5 h 3 h 6 h 24 h 48 h 72 h Hemocytedensity (x1000/µL) NaCl/Pi β-1,3-glucan ? ? ?
  • 11. RESEARCH QUESTIONS #1. Patterns and sites of hemocyte proliferation following an infection (circulating hemocytes, hematopoietic organ)? #3. Identification of cytokines involved in hemocyte recruitment during infection (cellular response, hemocyte proliferation)? #2. Development of a cell line (primary cell culture) using hemocytes or cells of hematopoietic organ? #4. Functional characterization of locust orthologue of angiotensin converting enzyme in the locust immune system? #1. Patterns and sites of hemocyte proliferation following an infection (circulating hemocytes, hematopoietic organ)? #3. Identification of cytokines involved in hemocyte recruitment during infection (cellular response, hemocyte proliferation)?
  • 13. 0 5 10 15 20 30h BrdU 30h BrdU + 6h NaCl/Pi 30h BrdU + 6h β-1,3- glucan %BrdUpositivehemocytes P<0.001 DAPI BrdU Merge Circulating hemocytes 30 h BrdU and 6 h β-1,3-glucan RESULTS: HEMOCYTE PROLIFERATION BrdU BrdU + β-1,3-glucan Hemocyte smear
  • 14. 0.0 0.5 1.0 1.5 2.0 2.5 Naive 3 6 Mitoticindex Hours post β-1,3-glucan injection P< 001 P<0.05H3S10PDAPI BrdU Merge RESULTS: HEMOCYTE PROLIFERATION Hematopoietic organ: 30 h BrdU DAPI H3S10P MergeBrdUBF 10 µm 10 µm Circulating hemocytes
  • 15. RESULTS: HEMOCYTE PROLIFERATION dv dv TUNELDAPI Hematopoietic organ 6 h β-1,3-glucan 0 10 20 30 40 50 4 d (+ 3 d) 6 d (+ 5 d) %BrdUpositivecells Time in days BrdU BrdU + β-1,3-glucan HPO Hematopoietic organ 4 d BrdU Nodule footprint Hematopoietic organ 4 d BrdU and 3 d β-1,3-glucan Hematopoietic organ 6 h post injection of S. lutea (left) and C. albicans (right)
  • 16. RESULTS: HEMOCYTE PROLIFERATION Circulating hemocytes Patterns and sites of hemocyte proliferation following an infection (circulating hemocytes, hematopoietic organ)? Hemocoel 0 2 4 6 8 10 0 h 0,5 h 3 h 6 h 24 h 48 h 72 h Hemocytedensity (x1000/µL) NaCl/Pi β-1,3-glucan
  • 17. RESEARCH QUESTION #2 Hemocoel ? Insect cytokines - Toll ligand (Spaëtzle) - Unpaired 3 - Vago - Growth blocking peptide (GBP) Hemocyte (plasmatocyte) +GBP [R/R] x(5-9)Cx2Gx(4-6)Gx(1-2)C[K/R] GBPN- -CSP 19-30 amino acid residues (≤ 3 kD)
  • 18. Hemolymph collection (20 mL) Hemocyte-free hemolymph (Serum) Serum fraction ( > 30 kD) Serum fraction ( < 30 kD) Control (-ve) 0.1x Lm-serum < 30 kD 0.1x 0.1x > 30 kD RESULTS: LOCUST GBP IDENTIFICATION Serum fractionation (30 kD MWCO filter)
  • 19. RESULTS: LOCUST GBP IDENTIFICATION 0 10 20 30 minutes 0 2 4 mAU(x1000) 0 40 80 %ACN 214nm,4nm (1.00) High-Performance Liquid Chromatography (HPLC) Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry (MALDI MS) < 30 kD Serum fractionation Liquid chromatography-mass spectrometry (LC-MS/MS) Intens(a.u.) m/z Von Willebrand factor type C Pacifastin Locust GBP RMIRLGDRCPAGTVQVLG TCRRVQKVNR
  • 20. RESULTS: LOCUST GBP IDENTIFICATION Control Lm GBP (1 nM) U S 0 50 100 0.01 0.1 1 10 100 1000 %hemocytespreading Concentration (nM) Control Lm GBP P < 0.05 P < 0.0001
  • 21. Exon Intron Cytoplasm Nucleus RNA mRNAAAA Structure of locust GBP encoding gene Expression profile of locust GBP encoding gene mRNAAAA Protein RESULTS: LOCUST GBP IDENTIFICATION AND CHARACTERIZATION Hemocoel ProGBP GBP
  • 22. RESULTS: LOCUST GBP IDENTIFICATION AND CHARACTERIZATION -1 0 1 2 HE FB BR VNC GL CA CC FM GT MT OV TE MAG Relativequantities(Log10) Immune system Central nervous system Endocrine glands Muscle Digestive tract Reproductive system ** ** ** **** * Expression profile of locust GBP encoding gene
  • 23. 0 2 4 6 8 10 0 h 0,5 h 3 h 6 h 24 h 48 h 72 h Hemocytedensity (x1000/µL) NaCl/Pi β-1,3-glucan Hemocoel Locust GBP RESULTS: LOCUST GBP IDENTIFICATION AND CHARACTERIZATION Identification of cytokines involved in hemocyte recruitment during infection (cellular response, hemocyte proliferation)?
  • 24. 0 2 4 6 8 10 0 h 0,5 h 3 h 6 h 24 h 48 h 72 h Hemocytedensity (x1000/µL) NaCl/Pi β-1,3-glucan FUTURE PROSPECTS Hemocoel Locust GBP Circulating hemocytes Function of locust GBP - Molecular mechanisms? - Functional studies (hemocyte proliferation, cross-talk and energy trade-offs)? - Solitary vs gregarious locust immunity? Hemocytes and phagocytic/hematopoietic organ - Other sources and hematopoietic organ as secondary roles in hemocyte production? - Prophylaxis (solitary vs gregarious)? - Translational research?
  • 25. ACKNOWLEDGMENT Prof. Roger Huybrechts Luc Vanden Bosch Dr. Kurt Boonen Ria Vanlaer Prof. Yoichi Hayakawa Saga University, Japan Prof. Lieve Van Mellaert, Rega Institute, Leuven Dr. Heiko Vogel, Max Plank Institute, Germany Prof. Veerle M. Darras Prof. Jozef Vanden Broeck Prof. Lieve Moons Prof. Dirk C. de Graaf Dr. Niels Wynant Dr. Sven Zels HSV-lab members Prof. Arckens-lab members Project students

Editor's Notes

  1. A synthetic nucleoside that is an analog of thymidine